FKBP12

FKBP12

CD31

CD34

Vascular tumours:

Papillary endothelial hyperplasia (Masson's lesion)

8/81

8/81

8/81

Capillary haemangioma

9/91

9/91

9/91

Kaposi's sarcoma

8/81

7/8(7 cases positive, 1 case equivocal)1

8/81

Epithelioid haemangioendothelioma

13/15(13 cases positive, 1 case equivocal)1

12/15(12 cases positive, 1 case equivocal)1

11/151

Angiosarcoma

18/191

19/191

11/18(11 cases positive, 1 case equivocal)1

Total for vascular tumours

(All 59 vascular tumours stained with at least one marker1)

56/591

55/591

47/581

Non-vascular tumours, by tissue microarray:

Squamous cell carcinoma of lung

1/161

1/311

Adenocarcinoma of lung

1/341

1/341

Squamous cell carcinoma of head and neck

1/281

Adenocarcinoma NOS of head and neck

1/11

1/11

Breast fibroadenoma

1/51

Intraduct carcinoma of breast

0/ 54(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 54(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 54(it is not clear how many of the cores in the microarrary were interpretable)1

Ductal carcinoma of breast

0/ 143(it is not clear how many of the cores in the microarrary were interpretable)1

2/931

0/ 143(it is not clear how many of the cores in the microarrary were interpretable)1

Lobular carcinoma of breast

1/81

Gastric adenocarcinoma

1/341

1/241

Colonic adenocarcinoma

0/ 87(it is not clear how many of the cores in the microarrary were interpretable)1

1/691

1/711

Cloacogenic anal carcinoma

1/21

Hepatocellular carcinoma

1/141

Conventional renal cell carcinoma

0/ 36(it is not clear how many of the cores in the microarrary were interpretable)1

2/331

2/311

Nephroblastoma

1/31

Renal oncocytoma

1/11

Transitional carcinoma of the bladder

0/ 25(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 25(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 25(it is not clear how many of the cores in the microarrary were interpretable)1

Prostatic carcinoma

23/781

5/781

Ovarian carcinoma

0/ 44(it is not clear how many of the cores in the microarrary were interpretable)1

1/371

0/ 44(it is not clear how many of the cores in the microarrary were interpretable)1

Endometrial carcinoma

0/ 26(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 26(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 26(it is not clear how many of the cores in the microarrary were interpretable)1

Uterine clear cell carcinoma

1/11

Papillary thyroid carcinoma

0/ 20(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 20(it is not clear how many of the cores in the microarrary were interpretable)1

4/191

Embryonal sarcoma

1/21

Adrenocortical carcinoma

2/41

1/41

Melanoma

1/191

Rosai-Dorfmann disease

2/21

Small lymphocytic lymphoma

2/61

Follicular lymphoma

1/21

Multiple myeloma

1/11

DLBCL

0/ 36(it is not clear how many of the cores in the microarrary were interpretable)1

0/ 36(it is not clear how many of the cores in the microarrary were interpretable)1

Mediastinal large cell lymphoma

1/111

Large cell lymphoma of spleen

2/111

Lymphoblastic lymphoma

2/41

Peripheral T cell lymphoma

1/31

Colonic T cell lymphoma

1/11

Cutaneous T cell lymphoma

1/11

Post transplant lymphoma

1/11

Mast cell disease

1/11

Solitary fibrous tumour

2/31

3/31

Gastrointestinal stromal tumour

6/101

Hibernoma

1/11

1/11

Liposarcoma

4/91

Myxoid liposarcoma

2/81

Leiomyosarcoma

5/101

MPNST

3/51

Malignant fibrous histiocytoma

3/111

Giant cell MFH

3/111

Alveolar soft part sarcoma

2/21

Total for non-vascular tumours

39/11011

42/10171

39/11011